Brief: Oryzon Gets "Intention To Grant" Communication For Patent Regarding vafidemstat
Sept 11 (Reuters) - Oryzon Genomics SA ORY.MC :
* RECEIVES "INTENTION TO GRANT" COMMUNICATION FOR PATENT
RELATING
TO USE OF VAFIDEMSTAT IN BORDERLINE PERSONALITY DISORDER
* "INTENTION TO GRANT" ISSUED BY THE EUROPEAN PATENT OFFICE
(EPO)
Source text: https://tinyurl.com/nhk2xpdv
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28